449 results on '"Boldt, Leif-Hendrik"'
Search Results
2. Semi-automated reproducible target transfer for cardiac radioablation – A multi-center cross-validation study within the RAVENTA trial
3. Left atrial conduction times and regional velocities in persistent atrial fibrillation patients with and without fibrotic atrial cardiomyopathy
4. Radiosurgery for ventricular tachycardia (RAVENTA): interim analysis of a multicenter multiplatform feasibility trial
5. The DZHK research platform: maximisation of scientific value by enabling access to health data and biological samples collected in cardiovascular clinical studies
6. Cardiac radioablation of incessant ventricular tachycardia in patients with terminal heart failure under permanent left ventricular assist device therapy—description of two cases
7. Occlusion of functional high-volume intra-atrial shunts in older patients after embolic stroke of undetermined source.
8. Magnetic field–induced interactions between phones containing magnets and cardiovascular implantable electronic devices: Flip it to be safe?
9. TandemHeart pLVAD
10. Recommendations regarding cardiac stereotactic body radiotherapy for treatment refractory ventricular tachycardia
11. Cardiac arrhythmias in patients with COVID-19: Lessons from 2300 telemetric monitoring days on the intensive care unit
12. Abstract 12554: Hipsc Derived Cardiomyocytes for Mechanistic, Patient Tailored Treatment in a Novel Mutation Linked to Cpvt
13. Converting PROMIS®-29 v2.0 profile data to SF-36 physical and mental component summary scores in patients with cardiovascular disorders.
14. Clinical outcome and intraprocedural characteristics of left atrial appendage occlusion: a comparison between single-occlusive plug-type and dual-occlusive disc-type devices.
15. Early clinical outcomes of Portico and Edwards Sapien 3 valve prosthesis in transcatheter aortic valve replacement: propensity-matched analysis.
16. Quantitative evaluation of different high-density 3D mapping modes for atrial and ventricular substrate assessment of cardiac arrhythmias with the HD grid catheter
17. Incidence and patterns of atrial fibrillation after catheter ablation of typical atrial flutter—the FLUTFIB study
18. Radiosurgery for ventricular tachycardia: preclinical and clinical evidence and study design for a German multi-center multi-platform feasibility trial (RAVENTA)
19. Is Marfan Syndrome Associated with Primary Structural Changes in the Left Atrium?
20. Protocol of the Berlin Long-term Observation of Vascular Events (BeLOVE): a prospective cohort study with deep phenotyping and long-term follow up of cardiovascular high-risk patients
21. STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe
22. Potential Usefulness and Clinical Relevance of Adding Left Atrial Strain to Left Atrial Volume Index in the Detection of Left Ventricular Diastolic Dysfunction
23. Effects of propofol on ventricular repolarization and incidence of malignant arrhythmias in adults
24. Katheterablation bei ventrikulärer Tachyarrhythmie: Klinische Ergebnisse
25. 2044: Radiosurgery for Ventricular Tachycardia (RAVENTA): Treatment Characteristics of a Multicenter Trial
26. STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe
27. STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe
28. Quality assurance process within the RAdiosurgery for VENtricular TAchycardia (RAVENTA) trial for the fusion of electroanatomical mapping and radiotherapy planning imaging data in cardiac radioablation
29. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage
30. Quality assurance process within the RAdiosurgery for VENtricular TAchycardia (RAVENTA) trial for the fusion of electroanatomical mapping and radiotherapy planning imaging data in cardiac radioablation
31. Treatment of Nonagenarians With Atrial Fibrillation: Insights From the Berlin Atrial Fibrillation (BAF) Registry
32. Mid-regional proadrenomedullin levels predict recurrence of atrial fibrillation after catheter ablation
33. hiPSC derived cardiomyocytes as a tool to test the clinical significance and drug effectiveness in a novel mutation linked to CPVT
34. Treatment Planning for Cardiac Radioablation: Multicenter Multiplatform Benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) Trial
35. Multidirectional Global Left Ventricular Systolic Function in Normal Subjects and Patients with Hypertension: Multicenter Evaluation
36. Minimal and deep sedation during ablation of ventricular tachycardia
37. Cardiac Implantable Electronic Device Interrogation at Forensic Autopsy: An Underestimated Resource?
38. First-in-human: leadless Micra transcatheter pacing system meets the Nanostim leadless cardiac pacing system
39. Atrial rhythm influences catheter tissue contact during radiofrequency catheter ablation of atrial fibrillation: comparison of contact force between sinus rhythm and atrial fibrillation
40. Catheter ablation of premature ventricular contractions in elderly patients: feasibility and success
41. Variations in the human soluble epoxide hydrolase gene and recurrence of atrial fibrillation after catheter ablation
42. Atrial fibrillation-induced cardiac troponin I release
43. Clinical Significance of the Assessment of the Systolic and Diastolic Myocardial Function of the Left Atrium in Patients With Paroxysmal Atrial Fibrillation and Low CHADS2 Index Treated With Catheter Ablation Therapy
44. Treatment Planning for Cardiac Radioablation: Multicenter Multiplatform Benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) Trial
45. Commercially Available Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes: Another Piece in Our Tool Box, but Not a Swiss Army Knife Yet
46. Normal range and usefulness of right ventricular systolic strain to detect subtle right ventricular systolic abnormalities in patients with heart failure: a multicentre study
47. Comparison of the anterior and posterior mitral isthmus ablation lines in patients with perimitral annulus flutter or persistent atrial fibrillation
48. Structural and functional cardiac analyses using modern and sensitive myocardial techniques in adult Pompe disease
49. AB-482901-005 FEASIBILITY OF RADIOSURGERY FOR VENTRICULAR TACHYCARDIA – PRIMARY ENDPOINT ANALYSIS FOR THE GERMAN MULTICENTER MULTIPLATFORM TRIAL RAVENTA
50. 321: Semi-automated reproducible target transfer for STAR – Cross-validation within the RAVENTA trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.